PAIGE JONES: Open Payments
NPI 1710655352 · SIDNEY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 27 payments from 9 companies in 2025. Trend: 2023 $479 · 2024 $165 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $188 |
| Viatris Specialty LLC | 4 | $61 |
| Lilly USA, LLC | 2 | $31 |
| Novo Nordisk Inc | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: UBRELVY, QULIPTA, YUPELRI, MOUNJARO, Ozempic, ACTHAR, Kerendia, JOURNAVX.
Industry payments across IA — which companies pay providers there.
